![]() 5-BDBD结构式
![]() |
常用名 | 5-BDBD | 英文名 | 5-BDBD |
---|---|---|---|---|
CAS号 | 768404-03-1 | 分子量 | 355.18500 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C17H11BrN2O2 | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | N/A | |
符号 |
![]() GHS07 |
信号词 | Warning |
5-BDBD用途5-BDBD是一种有效的选择性P2X4受体拮抗剂,可抑制rP2X4R介导的电流,IC50为0.75μM。5-BDBD可完全阻断硝酸甘油(NTG)诱导的基础和急性痛觉过敏[1][2]。 |
中文名 | 5-(3-溴苯基)-1,3-二氢-2H-苯并呋喃并[3,2-E] -1,4-二氮杂-2-酮 |
---|---|
英文名 | 5-(3-bromophenyl)-1,3-dihydro-[1]benzofuro[3,2-e][1,4]diazepin-2-one |
英文别名 | 更多 |
描述 | 5-BDBD是一种有效的选择性P2X4受体拮抗剂,可抑制rP2X4R介导的电流,IC50为0.75μM。5-BDBD可完全阻断硝酸甘油(NTG)诱导的基础和急性痛觉过敏[1][2]。 |
---|---|
相关类别 | |
靶点 |
I50: 0.75 μM (P2X4 receptor) |
体外研究 | 5-BDBD以浓度依赖性方式抑制表达rP2X4R的HEK293细胞的10µM ATP诱导电流,IC50为0.75μM[1]。5-BDBD向右移动ATP浓度响应曲线,EC50为4.7至15.9μM[1]。5-BDBD可专门用于区分P2X1R、P2X2aR、P2X2bR、P2X3R、P2X4R和P2X7R[1]。 |
体内研究 | 5-BDBD(28 mg/kg;i.p;每日9天)可完全阻断反复注射NTG引起的基底痛过敏[2]。动物模型:雄性C57BL/6小鼠[2]剂量:28mg/kg给药:腹腔注射。;结果:预防了NTG诱导的机械性超敏反应。 |
参考文献 |
分子式 | C17H11BrN2O2 |
---|---|
分子量 | 355.18500 |
精确质量 | 354.00000 |
PSA | 58.09000 |
LogP | 3.50550 |
储存条件 | 2-8°C,密封,干燥 |
Autocrine Regulation of UVA-Induced IL-6 Production via Release of ATP and Activation of P2Y Receptors.
PLoS ONE 10 , e0127919, (2015) Extracellular nucleotides, such as ATP, are released from cells in response to various stimuli and act as intercellular signaling molecules through activation of P2 receptors. Exposure to the ultravio... |
|
Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice.
Mol. Med. Report. 13 , 697-704, (2015) P2X4 receptor (P2X4R) is the most widely expressed subtype of the P2XRs in the purinergic receptor family. Adenosine triphosphate (ATP), a ligand for this receptor, has been implicated in the pathogen... |
5-bdbd |